National Research Corp (NRC) - Total Assets
Based on the latest financial reports, National Research Corp (NRC) holds total assets worth $134.56 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore NRC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
National Research Corp - Total Assets Trend (1993–2025)
This chart illustrates how National Research Corp's total assets have evolved over time, based on quarterly financial data. See shareholders equity of National Research Corp for net asset value and shareholders' equity analysis.
National Research Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
National Research Corp's total assets of $134.56 Million consist of 15.0% current assets and 85.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.1% |
| Accounts Receivable | $11.11 Million | 8.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.23 Million | 1.7% |
| Goodwill | $66.15 Million | 49.1% |
Asset Composition Trend (1993–2025)
This chart illustrates how National Research Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see National Research Corp market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: National Research Corp's current assets represent 15.0% of total assets in 2025, an increase from 0.0% in 1993.
- Cash Position: Cash and equivalents constituted 3.1% of total assets in 2025, up from 0.0% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 50.0% of total assets, an increase from 0.0% in 1993.
- Asset Diversification: The largest asset category is goodwill at 49.1% of total assets.
National Research Corp Competitors by Total Assets
Key competitors of National Research Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Forian Inc
NASDAQ:FORA
|
USA | $44.13 Million |
|
AIFORIA TECHNOLOGIES OYJ
F:L6J
|
Germany | €29.16 Million |
|
Principal Technologies Inc
V:PTEC
|
Canada | CA$870.31K |
|
FEEDBACK PLC LS-5
F:GZM0
|
Germany | €4.86 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
National Research Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.52 | 0.54 | 1.69 |
| Quick Ratio | 0.52 | 0.54 | 1.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-18.49 Million | $-17.37 Million | $27.61 Million |
National Research Corp - Advanced Valuation Insights
This section examines the relationship between National Research Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 30.43 |
| Latest Market Cap to Assets Ratio | 3.13 |
| Asset Growth Rate (YoY) | 1.8% |
| Total Assets | $134.88 Million |
| Market Capitalization | $422.56 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values National Research Corp's assets at a significant premium (3.13x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: National Research Corp's assets grew by 1.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for National Research Corp (1993–2025)
The table below shows the annual total assets of National Research Corp from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $134.88 Million | +1.76% |
| 2024-12-31 | $132.54 Million | +8.25% |
| 2023-12-31 | $122.44 Million | -6.15% |
| 2022-12-31 | $130.46 Million | -17.19% |
| 2021-12-31 | $157.54 Million | +18.08% |
| 2020-12-31 | $133.42 Million | +20.54% |
| 2019-12-31 | $110.69 Million | +2.79% |
| 2018-12-31 | $107.68 Million | -15.42% |
| 2017-12-31 | $127.32 Million | +5.55% |
| 2016-12-31 | $120.62 Million | -6.56% |
| 2015-12-31 | $129.10 Million | -0.32% |
| 2014-12-31 | $129.51 Million | +16.68% |
| 2013-12-31 | $111.00 Million | +10.94% |
| 2012-12-31 | $100.05 Million | -0.63% |
| 2011-12-31 | $100.68 Million | +5.29% |
| 2010-12-31 | $95.62 Million | +31.89% |
| 2009-12-31 | $72.50 Million | +2.62% |
| 2008-12-31 | $70.65 Million | +14.19% |
| 2007-12-31 | $61.87 Million | +0.55% |
| 2006-12-31 | $61.53 Million | +37.73% |
| 2005-12-31 | $44.67 Million | -6.84% |
| 2004-12-31 | $47.95 Million | +4.99% |
| 2003-12-31 | $45.67 Million | +17.62% |
| 2002-12-31 | $38.83 Million | +14.98% |
| 2001-12-31 | $33.77 Million | +6.75% |
| 2000-12-31 | $31.64 Million | +7.98% |
| 1999-12-31 | $29.30 Million | +11.41% |
| 1998-12-31 | $26.30 Million | +16.37% |
| 1997-12-31 | $22.60 Million | +264.52% |
| 1996-12-31 | $6.20 Million | +24.10% |
| 1995-12-31 | $5.00 Million | +41.17% |
| 1994-12-31 | $3.54 Million | +158.70% |
| 1993-12-31 | $1.37 Million | -- |
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, an… Read more